GIUSEPPINA MARIA PATAVINO

(Fonte: Lattes)
Índice h a partir de 2011
3
Lattes
Projetos de Pesquisa
Unidades Organizacionais
Instituto Central, Hospital das Clínicas, Faculdade de Medicina

Filtros

Limpar filtros

Configurações

Assunto: Medicine, Research & Experimental ×

Resultados de Busca

Agora exibindo 1 - 2 de 2
  • article 6 Citação(ões) na Scopus
    Risk factors for deferral due to low hematocrit and iron depletion among prospective blood donors in a Brazilian center
    (2015) DAUAR, Eloísa Tedeschi; PATAVINO, Giuseppina Maria; MENDRONE JÚNIOR, Alfredo; GUALANDRO, Sandra Fátima Menosi; SABINO, Ester Cerdeira; ALMEIDA-NETO, Cesar de
    OBJECTIVE: Deferral of blood donors due to low hematocrit and iron depletion is commonly reported in blood banks worldwide. This study evaluated the risk factors for low hematocrit and iron depletion among prospective blood donors in a large Brazilian blood center.METHOD: A case-control study of 400 deferred donors due to low hematocrit and 456 eligible whole blood donors was conducted between 2009 and 2011. Participants were interviewed about selected risk factors for anemia, and additional laboratory tests, including serum ferritin, were performed. Bivariate and multivariate analyses were performed to assess the association between predictors and deferral due to low hematocrit in the studied population and iron depletion in women.RESULTS: Donors taking aspirins or iron supplementation, those who reported stomachache, black tarry stools or hematochezia, and women having more than one menstrual period/month were more likely to be deferred. Risk factors for iron depletion were repeat donation and being deferred at the hematocrit screening. Smoking and lack of menstruation were protective against iron depletion.CONCLUSION: This study found some unusual risk factors related to gastrointestinal losses that were associated with deferral of donors due to low hematocrit. Knowledge of the risk factors can help blood banks design algorithms to improve donor notification and referral.
  • article 5 Citação(ões) na Scopus
    Contribution of the Retrovirus Epidemiology Donor Study (REDS) to research on blood transfusion safety in Brazil
    (2014) LOUREIRO, Paula; ALMEIDA-NETO, Cesar de; PROIETTI, Anna Bárbara Carneiro; CAPUANI, Ligia; GONÇALEZ, Thelma Terezinha; OLIVEIRA, Claudia Di Lorenzo de; LEÃO, Silvana Carneiro; LOPES, Maria Inês; SAMPAIO, Divaldo; PATAVINO, Giuseppina Maria; FERREIRA, João Eduardo; BLATYTA, Paula Fraiman; LOPES, Maria Esther Duarte; MENDRONE-JUNIOR, Alfredo; SALLES, Nanci Alves; KING, Melissa; MURPHY, Edward; BUSCH, Michael; CUSTER, Brian; SABINO, Ester Cerdeira
    The Retrovirus Epidemiology Donor Study (REDS) program was established in the United States in 1989 with the purpose of increasing blood transfusion safety in the context of the HIV/AIDS and human T-lymphotropic virus epidemics. REDS and its successor, REDS-II were at first conducted in the US, then expanded in 2006 to include international partnerships with Brazil and China. In 2011, a third wave of REDS renamed the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) was launched. This seven-year research program focuses on both blood banking and transfusion medicine research in the United States of America, Brazil, China, and South Africa. The main goal of the international programs is to reduce and prevent the transmission of HIV/AIDS and other known and emerging infectious agents through transfusion, and to address research questions aimed at understanding global issues related to the availability of safe blood. This article describes the contribution of REDS-II to transfusion safety in Brazil. Articles published from 2010 to 2013 are summarized, including database analyses to characterize blood donors, deferral rates, and prevalence, incidence and residual risk of the main blood-borne infections. Specific studies were developed to understand donor motivation, the impact of the deferral questions, risk factors and molecular surveillance among HIV-positive donors, and the natural history of Chagas disease. The purpose of this review is to disseminate the acquired knowledge and briefly summarize the findings of the REDS-II studies conducted in Brazil as well as to introduce the scope of the REDS-III program that is now in progress and will continue through 2018.